Free Trial

Canopy Growth (TSE:WEED) Trading Up 8.5% - Here's What Happened

Canopy Growth logo with Medical background

Key Points

  • Canopy Growth Corp shares rose by 8.5% to C$1.92, with trading volume increasing by 17% compared to the average daily volume.
  • ATB Capital downgraded Canopy Growth's target price from C$3.20 to C$1.60, reflecting a consensus rating of "Sell" among analysts.
  • The company has a debt-to-equity ratio of 120.38 and currently holds a market capitalization of C$305.65 million.
  • Need better tools to track Canopy Growth? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Canopy Growth Corp (TSE:WEED - Get Free Report)'s stock price shot up 8.5% on Monday . The company traded as high as C$1.98 and last traded at C$1.92. 2,564,313 shares changed hands during mid-day trading, an increase of 17% from the average session volume of 2,194,354 shares. The stock had previously closed at C$1.77.

Wall Street Analyst Weigh In

Separately, ATB Capital dropped their target price on shares of Canopy Growth from C$3.20 to C$1.60 and set an "underperform" rating on the stock in a report on Tuesday, June 3rd. Two investment analysts have rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of "Sell" and a consensus target price of C$1.55.

Read Our Latest Research Report on WEED

Canopy Growth Price Performance

The company has a current ratio of 1.39, a quick ratio of 2.32 and a debt-to-equity ratio of 120.38. The business's fifty day moving average is C$1.69 and its 200 day moving average is C$1.82. The firm has a market capitalization of C$339.43 million, a P/E ratio of -0.31, a P/E/G ratio of -0.01 and a beta of 1.79.

Insiders Place Their Bets

In other Canopy Growth news, Director David Angelo Lazzarato sold 15,701 shares of the company's stock in a transaction that occurred on Monday, June 30th. The shares were sold at an average price of C$1.68, for a total value of C$26,307.34. Corporate insiders own 0.21% of the company's stock.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Featured Articles

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines